Strategies for Making a Sec. 338 (h)(10) Election
Bloomberg BNA US Taxation of Mergers and Acquisitions Conference
02 December 2014
1:15-2:15 p.m. CST
Gardere Partner James Howard, chair of the Firm's Tax Practice Group, is presenting "Strategies for Making a Sec. 338 (h)(10) Election" at the upcoming Bloomberg BNA U.S. Taxation of Mergers and Acquisitions conference in Houston. Mr. Howard will discuss situations when a stock purchase can be treated like an asset purchase, the benefits of electing asset sale treatment, and considerations for both the buyer and the seller.
The two-day conference provides a technical update for practitioners on the latest tax strategies and techniques in structuring both domestic and cross-border acquisitions, as well as the latest developments in tax regulations and regulatory pronouncements. CPE and CLE credit is available.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.